ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit... (ffalo. While all plantsproduce anthocya...)

ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds

Date:7/21/2008

ffalo. "While all plants produce anthocyanins, they are challenging to extract and study in well-defined mixtures. Now that we can harvest them from a lab, they can be further studied for their antioxidant and other properties in various indications, especially ones related to the treatment of the metabolic syndrome, i.e. chronic pathological conditions stemming from obesity."

ChromaDex plans to market these new, natural ingredients to food, beverage, pharmaceutical and supplement manufacturers in order to meet the growing demands for natural, plant-based ingredients in the marketplace. The company will also evaluate opportunities to partner the ingredients for expanded applications.

Under the terms of the agreement, ChromaDex agreed to pay an annual minimum royalty payment to SUNY Buffalo and a milestone payment upon sale of the first licensed product, licensed service or sublicense fee payment received by ChromaDex. With the consent of SUNY Buffalo, ChromaDex may also grant sublicenses to third parties and has agreed to reimburse SUNY Buffalo for certain patent costs related to the licensed patents.

About ChromaDex

ChromaDex is a world leader in the development of Phytochemical and Botanical Reference Standards and the creation of associated intellectual property. ChromaDex is committed to sustainable "Green chemistry" and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools and services to meet product regulatory, quality, efficacy and safety standards.

Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to ability to market, produce and sell the referenced ingredients, risks relating to product and customer de
'/>"/>

SOURCE ChromaDex Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
2. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
3. NuVasive Licenses Its Insert and Rotate Technology
4. GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals
5. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
6. Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics
7. HealthTek Software Solutions Licenses First DataBanks OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution
10. Cyberonics Licenses Obesity-Related Patents
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries

Post Your Comments:

(Date:12/14/2009)... YORK, Dec. 14 Josie Raper, a 29 year-old ... in six months with the help of the Dr. Siegal,s ... on the Joy Fit Club segment on NBC,s Today Show. ... Joy Bauer, airs twice a month and salutes those who ... in 2007 and has kept it off for two years. ...

(Date:12/14/2009)... Athens, Ga. A new study published by researchers ... Center in Tampa, Fla., has found that cancer patients ... patients with cancer alone, even after controlling for factors ... But the study, published in the early online edition ... also argues that a diagnosis of dementia shouldn,t discourage ...

(Date:12/14/2009)... of medication-related problems, including under treatment, suboptimal drugs, suboptimal ... their quality of life. Now new research (1), from ... of North Carolina at Chapel Hill shows that blacks ... medical regimens is a particular issue for this group. ... disparities in the quality of medication use appears this ...

(Date:12/14/2009)... clothing supplier, MPE, offers protective garments online to military and ... ... Hammond, Ind. (PRWEB) December 14, 2009 -- Miller,s Precision ... garments , announces its recent approval as a vendor on ... approved DOD EMALL vendor, MPE can provide military, government and ...

(Date:12/14/2009)... Racial disparities seen for ,standard-of-care, breast cancer treatment, study ... new study finds a significant racial disparity in breast ... white counterparts to receive radiation therapy after a lumpectomy. ... care for the treatment of breast cancer that is ... published in the Dec. 14 issue of the journal ...

Breaking Medicine News(10 mins):Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4 Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2 Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3 Health News:Racial differences in medication use 2 Health News:MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL 2 Health News:After Lumpectomy, Radiation Rates Lower for Black Women 2

[0] Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club [0] Study finds significantly worse outcomes in cancer patients with cognitive impairment [0] Racial differences in medication use [0] MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL [0] After Lumpectomy, Radiation Rates Lower for Black Women

... Disease Patients Rising, CHICAGO, April 2 ... disease and, according to the latest research,from Prevent ... number,is continuing to climb. With more than 130 ... million suffer from leading causes of vision loss ...

... Ready for Action on the House Floor, WASHINGTON, ... Bernadette A. Toomey, President and CEO, American Lung,Association:, ... Energy and Commerce Committee for its passage of the ... urge the full,House to quickly take action to move ...

... more, it predicts major episodes, study finds , , WEDNESDAY, ... in young adults can increase their risk of developing ... of almost 600 young adults found that those with ... sleeplessness gradually increased over two decades, especially among women. ...

... would welcome an advance promising to dramatically reduce their ... at Washington University School of Medicine in St. Louis ... The researchers focused a powerful drug directly on tumors ... drug dose 1,000 times lower than used previously for ...

... Sebring Convertible Winner To Be Part Of Live Auction At ADA,s ... Annual Gala At Ritz-Carlton Dearborn, Donation By Chrysler Jeep Superstores Will Help Children ... ... Diabetes research,advocacy and education received a big boost thanks to the generous ...

... are running for president or looking for a clerical ... are a woman, Yale University psychologist Victoria Brescoll has ... recently completed three separate studies to explore a phenomenon ... Senator Hillary Clinton: People accept and even reward men ...

Other Medicine News:Health News:Eye Disease Continuing to Increase Among Americans 2 Health News:Eye Disease Continuing to Increase Among Americans 3 Health News:Persistent Insomnia Leads to Depression in Young Adults 2 Health News:Nano-sized technology has super-sized effect on tumors 2 Health News:Nano-sized technology has super-sized effect on tumors 3 Health News:Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible 2 Health News:Studies' message to women: Keep your cool 2

Eye Disease Continuing to Increase Among Americans American Lung Association Applauds Energy and Commerce Committee for its Strong Commitment to Protecting Public Health From the Dangers of Tobacco Persistent Insomnia Leads to Depression in Young Adults Nano-sized technology has super-sized effect on tumors Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible Studies' message to women: Keep your cool

(Date:12/14/2009)... 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... had received a complete response letter from the ... its New Drug Application ("NDA") for Onrigin(TM) (laromustine) ... indicates that the FDA cannot approve the Company,s ... to address remaining issues. ,, Alan Kessman, Chief ...

(Date:12/14/2009)... Cancer patients in Finland have gained access to ... radiotherapy technology from Varian Medical Systems (NYSE: ... clinic in the Nordic region. Clinicians at Docrates ... precise form of radiotherapy to treat patients with ... and prostate. ,, RapidArc, which enables clinicians to ...

(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...

[0] Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration [0] Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments [0] Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014

... fair coloring traits contribute to risk, of skin cancer; ... REYKJAVIK, Iceland, May 18 In two papers published,today, ... U.S.,expand upon the company,s recent findings in the genetics ... that certain of these,common variants also confer risk of ...

... and under-studied population ... important insights -, SAN DIEGO, Calif., May 18 ... largest prospective study to evaluate the,response of Latino whites ... therapy with pegylated interferon plus ribavirin. The,results showed PEGASYS(R) ...

Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2 deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3 deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 2 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 3 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 4 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 5 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 6 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 7 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 8

deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C

1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...

... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...

... Bioglue Surgical Adhesive (Bioglue) is a ... bovine serum albumin (BSA) and glutaraldehyde. ... exclusively from bovine spongiform encephalopathy (BSE) ... reduces or inactivates viruses. The solutions ...

... Cebus is Plasmaseal's low cost, low volume ... and the plasma is separated from whole blood ... plasma is transferred to the Cebus single use ... for 30 seconds to activate the concentrating process. ...

Medicine Products:

Delta System Sononav Intraoperative Imaging System Bioglue Cebus

ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit...(ffalo. While all plantsproduce anthocya...),Health